Clinical Trials Browser

Phase 2 × Withdrawn × Radiation Dose Hypofractionation × Clear all

NCT05161533 2023-10-18

Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial

Phase 2 Withdrawn

Lung Neoplasms

NCT03419130 2018-12-07

Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer

Phase 2 Withdrawn

Infiltrating Bladder Urothelial Carcinoma

NCT02947113 2017-11-30

HYPOLAN

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Neoplasms